Article

COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers

2020-06-11

Abstract excerpt

<h4>Importance</h4> New York City is a global epicenter for the SARS-CoV-2 outbreak with a significant number of individuals infected by the virus. Patients with multiple myeloma have a compromised immune system, due to both the disease and anti-myeloma therapies, and may therefore be particularly susceptible to coronavirus disease 2019 (COVID-19); however, there is limited information to guide clinical management...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d12582b2-cea7-5bff-878b-f11c91a99929
DOI: 10.1101/2020.06.09.20126516

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centersDOI 10.1101/2020.06.09.20126516Read

Outpatient anti-spike monoclonal antibody administration is associated with decreased morbidity and mortality among patients with cancer and COVID-19Semantic proximity Read

Challenges, Difficulties, and Delayed Diagnosis of Multiple MyelomaSemantic proximity Read

Multicenter cohort study of the risk factors and mortality of Omicron variant SARS-CoV-2-infected patients with hematologic malignancies in hospitalsSemantic proximity Read

Identifying Determinants of Survival Disparities in Multiple Myeloma Patients Using Electronic Health Record Data.Semantic proximity Read

COVID-19 severity in patients with chronic lymphocytic leukemia treated with venetoclax: a single-center observational cohort studySemantic proximity Read

New insights into genetic characteristics between multiple myeloma and COVID‐19: An integrative bioinformatics analysis of gene expression omnibus microarray and the cancer genome atlas dataSemantic proximity Read

Time trends in survival and causes of death in multiple myeloma: a population-based study from GermanySemantic proximity Read

Quantify the Contribution of Modifiable Risk Factors for Progression of MGUS to Multiple MyelomaSemantic proximity Read

Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group databaseSemantic proximity Read

Pattern of Use and Efficacy of Daratumumab-based Therapy in Patients With Multiple Myeloma in a Real-world Setting: a Single Institution ExperienceSemantic proximity Read

Characteristics and outcomes of coronavirus disease 2019 (COVID-19) patients with cancer: A single-center retrospective observational study in Tokyo, JapanSemantic proximity Read

Patients with CLL have similar high risk of death upon the omicron variant of COVID-19 as previously during the pandemicSemantic proximity Read